BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    SYNVISC HYLAN G-F-20

    MDR report key: 10811162 · Received November 6, 2020

    Report

    Report Number
    MW5097718
    Event Type
    Malfunction
    Date Received
    November 6, 2020
    Date of Event
    February 3, 2000
    Report Date
    December 11, 2000
    Manufacturer
    GENZYME CORPORATION
    Product Code
    MOZ
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    NV, US
    Reporter Occupation
    003

    Narratives

    Description of Event or Problem · 1

    I WAS GIVEN SYNVISC IN MY HAND. IT WAS APPROVED FOR KNEES ONLY. I HAVE HAD SEVERE SWELLING, PAIN AND MENTAL DISTRESS SINCE. THE DOCTOR THAT GAVE ME THIS TREATMENT NEVER ONCE TOOK ANY TESTS OR X-RAYS BEFORE TREATING ME WITH THIS TREATMENT. I HAVE SINCE HAD SURGERY TO REPAIR MY HAND AND I WAS BLOWN OFF MY BIOMATRIX INC. AND THE DOCTOR THAT GAVE ME THIS TREATMENT. I WANT SATISFACTION. I AM AT THE PRESENT TIME UNABLE TO WORK AND NOW MY FINANCIAL SITUATION IS NOT GOOD, PLEASE HELP ME. SINCE THE TREATMENT I WENT TO ANOTHER DOCTOR AND HE DID THE NERVE TEST TO SHOW THAT I HAD CARPAL TUNNEL, AND I NEEDED SOME PAINFUL HARDWARE REMOVED. ALSO I HAD SCAR TISSUE ON THE RADIAL NERVE. (B)(4).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1262993 SYNVISC HYLAN G-F-20 ACID, HYALURONIC, INTRAARTICULAR MOZ GENZYME CORPORATION

    Patients

    Seq Age Sex Outcome Treatment
    1 45 YR Other